Insider Selling: Veeva Systems (NYSE:VEEV) Insider Sells $9,008,280.00 in Stock

Veeva Systems Inc. (NYSE:VEEVGet Free Report) insider Thomas Schwenger sold 36,000 shares of the stock in a transaction on Thursday, August 13th. The shares were sold at an average price of $250.23, for a total value of $9,008,280.00. Following the completion of the transaction, the insider owned 19,449 shares in the company, valued at $4,866,723.27. The trade was a 64.92% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Veeva Systems Stock Up 3.4%

VEEV stock opened at $251.01 on Thursday. The company has a market cap of $40.77 billion, a P/E ratio of 44.74, a PEG ratio of 1.04 and a beta of 0.92. Veeva Systems Inc. has a twelve month low of $148.05 and a twelve month high of $310.50. The business has a fifty day moving average of $194.64 and a 200-day moving average of $181.16.

Veeva Systems (NYSE:VEEVGet Free Report) last issued its quarterly earnings results on Wednesday, June 3rd. The technology company reported $2.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.14 by $0.10. The business had revenue of $882.95 million for the quarter, compared to analyst estimates of $857.73 million. Veeva Systems had a return on equity of 13.72% and a net margin of 28.37%.The firm’s revenue for the quarter was up 16.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.97 earnings per share. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. As a group, equities research analysts anticipate that Veeva Systems Inc. will post 6.65 earnings per share for the current fiscal year.

Institutional Trading of Veeva Systems

Hedge funds have recently modified their holdings of the company. Greenleaf Trust acquired a new position in Veeva Systems during the second quarter valued at approximately $260,000. New Mexico Educational Retirement Board acquired a new stake in Veeva Systems in the second quarter worth $1,349,000. Field & Main Bank acquired a new stake in Veeva Systems in the second quarter worth $29,000. Livforsakringsbolaget Skandia Omsesidigt bought a new position in shares of Veeva Systems during the second quarter worth $142,000. Finally, North Star Asset Management Inc. bought a new position in shares of Veeva Systems during the second quarter worth $27,390,000. 88.20% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages have recently commented on VEEV. Mizuho lowered their price target on shares of Veeva Systems from $295.00 to $270.00 and set an “outperform” rating for the company in a research report on Thursday, June 4th. BNP Paribas Exane restated an “outperform” rating and issued a $285.00 price objective on shares of Veeva Systems in a report on Thursday, June 4th. The Goldman Sachs Group reduced their price objective on shares of Veeva Systems from $190.00 to $165.00 and set a “sell” rating on the stock in a research note on Thursday, June 4th. Oppenheimer upped their target price on shares of Veeva Systems from $225.00 to $300.00 and gave the company an “outperform” rating in a research report on Monday. Finally, Citigroup upped their target price on shares of Veeva Systems from $176.00 to $190.00 and gave the company a “neutral” rating in a research report on Thursday, June 4th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Veeva Systems presently has an average rating of “Moderate Buy” and an average price target of $253.75.

Read Our Latest Report on VEEV

Veeva Systems News Summary

Here are the key news stories impacting Veeva Systems this week:

  • Positive Sentiment: Higher analyst targets support the stock: Barclays’ target implies further upside, and Stifel Nicolaus is also forecasting strong appreciation. The consensus rating remains “Moderate Buy,” with institutional ownership at approximately 88%. Barclays raises Veeva Systems price target Stifel Nicolaus forecasts appreciation
  • Positive Sentiment: Upcoming earnings are a potential catalyst: Veeva is expected to report quarterly results on Wednesday. Its prior quarter beat estimates, delivering $2.24 in EPS versus a $2.14 consensus and $882.95 million in revenue versus an $857.73 million estimate. Veeva Systems expected earnings release
  • Neutral Sentiment: Analyst views remain mixed: Several firms maintain bullish ratings, but earlier target reductions from Canaccord Genuity, BMO Capital Markets and Goldman Sachs indicate concerns about valuation and growth. The average target is near the current trading range, limiting the immediate upside implied by the broader consensus. Wall Street analysts on Veeva Systems
  • Negative Sentiment: Growth concerns and insider selling remain risks: Veeva has underperformed the broader market amid softer demand and competition. In addition, insider Thomas Schwenger sold $9.0 million of shares under a pre-arranged Rule 10b5-1 plan, reducing his holdings by nearly 65%. Veeva Systems insider sale

Veeva Systems Company Profile

(Get Free Report)

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.

Featured Articles

Insider Buying and Selling by Quarter for Veeva Systems (NYSE:VEEV)

Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.